Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tom Tencer"'
Autor:
Anthony Bewley, Jonathan Barker, Farhan Mughal, Helene Cawston, Vidya Damera, James Morris, Tom Tencer
Publikováno v:
Cogent Medicine, Vol 5, Iss 1 (2018)
Purpose: Apremilast, an oral phosphodiesterase-4 inhibitor, is effective and well tolerated in the treatment of moderate-to-severe psoriasis. The cost-effectiveness of introducing apremilast before biologics was assessed from a UK payer perspective.
Externí odkaz:
https://doaj.org/article/ea4d12e12591470083c82b1005e35f3e
Autor:
Allie Cichewicz, Tom Tencer, Komal Gupte-Singh, Sonya Egodage, Heather Burnett, Jinender Kumar
Publikováno v:
Advances in Therapy. 40:2116-2146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0b95d32683e5763cacbbd43e09def1c
https://doi.org/10.1007/s12325-023-02488-z
https://doi.org/10.1007/s12325-023-02488-z
Publikováno v:
ClinicoEconomics and Outcomes Research. 15:125-138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::413e7d6bafd867dcb3c7c9f7871b2259
https://doi.org/10.2147/ceor.s391413
https://doi.org/10.2147/ceor.s391413
Publikováno v:
CNS Drugs
Background Patients with multiple sclerosis (MS) experience relapses and sustained disability progression. Since 2004, the number of disease-modifying therapies (DMTs) for MS has grown substantially. As a result, patients, healthcare providers, and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c572a2ebc5a8f5b19e3f653a060c141f
https://doi.org/10.1007/s40263-021-00805-0
https://doi.org/10.1007/s40263-021-00805-0
Autor:
Elyse Swallow, Timothy Pham, Oscar Patterson-Lomba, Lei Yin, Andres Gomez-Lievano, Jingyi Liu, Tom Tencer, Komal Gupte-Singh
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104551
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::221fd2a96b823e1d1e4ac321699fa2e7
https://doi.org/10.1016/j.msard.2023.104551
https://doi.org/10.1016/j.msard.2023.104551
This systematic literature review (SLR) assessed the effects of endoscopic mucosal healing and histologic remission on clinical, quality-of-life (QoL), and economic outcomes in adults with ulcerative colitis (UC) in the real-world setting. Literature
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef34db19dc27b8b8a084cab1c766d69e
Autor:
Tom Tencer, Komal Gupte-Singh, Raymond K. Cross, Ryan W. Harrison, Samantha J. Kerti, Jinender Kumar, Gursimran Kochhar, Bincy Abraham, Jacqueline O’brien
Publikováno v:
American Journal of Gastroenterology. 116:S1379-S1380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ee10822bcfcb6d7133873881cde903
https://doi.org/10.14309/01.ajg.0000786928.49906.4d
https://doi.org/10.14309/01.ajg.0000786928.49906.4d
Publikováno v:
Gastroenterology. 162:S-529
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::743f13dc50b28b074d7b970dd80a05ad
https://doi.org/10.1016/s0016-5085(22)61260-5
https://doi.org/10.1016/s0016-5085(22)61260-5
Publikováno v:
Gastroenterology. 162:S-1036
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c474fe0cead785be79fe8f608831af6
https://doi.org/10.1016/s0016-5085(22)62466-1
https://doi.org/10.1016/s0016-5085(22)62466-1
Publikováno v:
Journal of Crohn's and Colitis. 15:S511-S512
Background Current approved therapies for the treatment of moderate-to-severe ulcerative colitis (UC) have well-established efficacy; however, some patients may fail to respond or may lose their response over time, resulting in dose escalation or tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27c78a26ab0958564192d3fccf41b5cb
https://doi.org/10.1093/ecco-jcc/jjab076.661
https://doi.org/10.1093/ecco-jcc/jjab076.661